Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Vaccines

Free Subscription 19.10.2026 3 BMJ 1 Clin Microbiol Rev 1 J Infect 4 J Infect Dis 1 JAMA 1 Lancet 1 MMWR Morb Mortal Wkly Rep 1 Nat Med 1 Pediatr Infect Dis J 1 PLoS Med 5 PLoS One 15 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. COOMBES R
   Vaccine target of 100 days isn't fast enough, says CEPI chair-while expert warns of failure to provide basic care in DRC Ebola outbreak.
   BMJ. 2026;395:e101166.
   PubMed        
   
   
2. AHILLAN T
   Pandemic preparations: UK government announces multimillion pound fund to develop potential vaccines.
   BMJ. 2026;395:e101135.
   PubMed        
   
   
3. TANNE JH, Looi MK
   RFK Jr opens NIH clinic to investigate vaccine injuries, announces reporting reforms.
   BMJ. 2026;395:e101129.
   PubMed        
   
   

   
   Clin Microbiol Rev

4. BAHATI SY, Maghembe RS
   Invasive non-typhoidal Salmonella disease in the vaccine-development era: diagnostic blind spots, antimicrobial resistance, genomic transmission, and prevention.
   Clin Microbiol Rev. 2026 Oct 14:e0020126. doi: 10.1128/cmr.00201.
   PubMed         Abstract available
   
   

   
   J Infect

5. LEKHULENI C, Ndlangisa K, de Gouveia L, Chochua S, et al
   Antimicrobial resistance trends and lineage distribution among invasive pneumococcal disease isolates pre- and post-pneumococcal conjugate vaccine introduction, South Africa.
   J Infect. 2026 Oct 15:106878. doi: 10.1016/j.jinf.2026.106878.
   PubMed         Abstract available
   
   

   
   J Infect Dis

6. BUCRIS E, Levin T, Azar R, Mannasse B, et al
   Rapid Differentiation of Vaccine and Wild-Type Measles Virus During an Ongoing Outbreak using a new molecular assay.
   J Infect Dis. 2026 Oct 15:jiag518. doi: 10.1093.
   PubMed         Abstract available
   
   
7. ROGERS S, Sumner KM, Yang Y, Johnson E, et al
   Protective effects of influenza B neuraminidase antibodies against symptomatic influenza virus infection.
   J Infect Dis. 2026 Jul 10:jiag351. doi: 10.1093.
   PubMed         Abstract available
   
   
8. MOORE HC, Foo D, Giannini F, Minney-Smith C, et al
   What is the Optimal RSV Immunization Strategy for Infants Born in the RSV Off-season?
   J Infect Dis. 2026;234:e823-e828.
   PubMed         Abstract available
   
   
9. SUTCLIFFE CG, Sergent VM, Yazzie D, Brasinikas G, et al
   Post-COVID Rebound in Invasive Pneumococcal Disease Driven by Resurgence of Serotype 4 Among American Indian Individuals in the Southwest United States.
   J Infect Dis. 2026;234:e908-e921.
   PubMed         Abstract available
   
   

   
   JAMA

10. RICHMOND S
    Demand for Vaccination Increases Amid Pennsylvania Measles Outbreak.
    JAMA. 2026 Oct 16. doi: 10.1001/jama.2026.20019.
    PubMed        
    
    

    
    Lancet

11. TURTLE L, Subramaniam K
    Making every vial count: fractional dosing of yellow fever vaccine.
    Lancet. 2026;408:1528-1529.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

12. NEWELL K, Ohlsen E, Moore K, Aho S, et al
    Effectiveness of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Children Aged 6 Months-6 Years During a Statewide Pertussis Outbreak - Alaska, May-November 2024.
    MMWR Morb Mortal Wkly Rep. 2026;75:601-606.
    PubMed         Abstract available
    
    

    
    Nat Med

13. SELLARS MC, Frank JA, Shim B, Vanasse A, et al
    Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial.
    Nat Med. 2026 Oct 14. doi: 10.1038/s41591-026-04717.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

14. TENENBAUM T, Martin L
    The Role of Vaccination in Antimicrobial Resistance Prevention in Children.
    Pediatr Infect Dis J. 2026 Oct 14. doi: 10.1097/INF.0000000000005438.
    PubMed        
    
    

    
    PLoS Med

15. WENGER CGC, Grantz KH, Menkir TF, Muellenmeister AM, et al
    Evaluating the impact and cost-effectiveness of typhoid conjugate vaccine schedules across diverse settings: A multi-model comparison.
    PLoS Med. 2026;23:e1005280.
    PubMed         Abstract available
    
    

    
    PLoS One

16. AYELE F, Assebe T, Mandefro M, Admassu Ayana D, et al
    Prevalence and genotype distribution of norovirus and rotavirus among children under five with diarrheal infection in lower-middle-income countries after Rotavirus vaccine introduction: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0359886.
    PubMed         Abstract available
    
    
17. HASNAT MS, Saim AS, Sarmin MFA, Mitro P, et al
    Designing a multi-epitope vaccine against La Crosse virus using immunoinformatics approach.
    PLoS One. 2026;21:e0359567.
    PubMed         Abstract available
    
    
18. KISA A, Kisa S
    Methodological drivers, reporting completeness, and transferability in HPV vaccination economic evaluations: A scoping review.
    PLoS One. 2026;21:e0360732.
    PubMed         Abstract available
    
    
19. YANG Y, Juntila-Raymond C, Callear A, Smith M, et al
    Evaluation of pre-Omicron population immunity for SARS-CoV-2 in the Household Influenza Vaccine Evaluation (HIVE) cohort.
    PLoS One. 2026;21:e0360506.
    PubMed         Abstract available
    
    
20. VOLASOA MH, Andrianarivelo SMJ, Albrechtova K, Raharijaona F, et al
    Owned dog population profile, dog ownership and bite risk determinants: Key steps to rabies control in Antananarivo, Madagascar.
    PLoS One. 2026;21:e0360417.
    PubMed         Abstract available
    
    

    
    Vaccine

21. HAMMOUD M, Holt M, Broady TR, Grulich A, et al
    High willingness to receive a vaccine for gonorrhoea prevention among gay, bisexual, queer, and other sexuality diverse men, and non-binary people in Australia.
    Vaccine. 2026;94:129233.
    PubMed         Abstract available
    
    
22. PRASERT K, Nakphook S, Kittiwatanachod J, Ditsungneon D, et al
    Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 mug HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA.
    Vaccine. 2026;94:129230.
    PubMed         Abstract available
    
    
23. MARQUES DFP, Howard J, Alvarez ML, Machado A, et al
    Comparing two case definitions for including severe acute respiratory infection patients in influenza and COVID-19 vaccine effectiveness studies among older adults using the test-negative design: VEBIS hospital network, seven European countries, 2023/
    Vaccine. 2026;94:129234.
    PubMed         Abstract available
    
    
24. MONATH TP, Fusco J, Erbelding E, Kemp T, et al
    rVSV-DeltaG-EBOV-GP-Nipah-G (also designated PHV02) replication-competent, recombinant vesicular stomatitis virus vaccine for prevention of Nipah virus disease: Standardized template with key considerations for a risk/benefit assessment.
    Vaccine. 2026 Oct 13:129113. doi: 10.1016/j.vaccine.2026.129113.
    PubMed         Abstract available
    
    
25. ROGOLL L, Schulz K, Gerdes U, Sauter-Louis C, et al
    BTV-3 vaccination decisions among German livestock farmers: a KAP survey.
    Vaccine. 2026;94:129228.
    PubMed         Abstract available
    
    
26. PRENDERGAST L, Begley E, Savoury M, Stielke A, et al
    Exploring the broader social value outcomes reported in economic evaluations of vaccination programmes across the life course: A scoping review.
    Vaccine. 2026;94:129226.
    PubMed         Abstract available
    
    
27. TOME J, Schwind JS, Richmond HL, Deloach B, et al
    Vaccine recipient and volunteer experiences from COVID-19 mass vaccine clinics at a university campus: drive-through and walk-through approaches.
    Vaccine. 2026;94:129229.
    PubMed         Abstract available
    
    
28. MUZARAP D, Dzhaldybayeva A, Mambetaliyev M, Ostapchuk Y, et al
    Evaluation of the immunobiological properties of the attenuated strain CP-65 K for the development of a cowpox vaccine.
    Vaccine. 2026;94:129239.
    PubMed         Abstract available
    
    
29. BRADY C, Govender M, Mellors J, Tipton T, et al
    Spike antibody Fc is associated with protection from SARS-CoV-2 challenge in macaques.
    Vaccine. 2026;93:129192.
    PubMed         Abstract available
    
    
30. EKAWATI FM, Azizah AH, Lisa HRA, Trilaksono R, et al
    Understanding rotavirus vaccine acceptance in Indonesia: a WHO BeSD-based exploration of parents' and religious leaders' perspectives in three provinces.
    Vaccine. 2026;94:129211.
    PubMed         Abstract available
    
    
31. SUTIN AR, Luchetti M, Mousa JJ, Stephan Y, et al
    Purpose in life and shingles vaccination and infection.
    Vaccine. 2026;94:129243.
    PubMed         Abstract available
    
    
32. PARK SY, Huh HJ, Choi S, Chung JW, et al
    Waning immunity, an age shift, and rising adult burden of varicella after two decades of single-dose vaccination in South Korea.
    Vaccine. 2026;94:129240.
    PubMed         Abstract available
    
    
33. YAMAMOTO S, Matsuda K, Maeda K, Mizoue T, et al
    Protection of Omicron XBB.1.5 vaccine, previous infection, and their induced neutralizing antibodies against symptomatic SARS-CoV-2 infection during Omicron KP.3 wave.
    Vaccine. 2026;94:129242.
    PubMed         Abstract available
    
    
34. BAI JPF, Beigmohammadi F, Craig M, Dalton M, et al
    Corrigendum to "The case for model-informed vaccine development" [Vaccine 92 (2026) 128780].
    Vaccine. 2026 Oct 15:129245. doi: 10.1016/j.vaccine.2026.129245.
    PubMed        
    
    
35. NIEMINEN T, Nurhonen M, Leino T, Salo H, et al
    Cost-effectiveness of universal infant hepatitis B vaccination programme in Finland.
    Vaccine. 2026;94:129171.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum